Lake Street Initiates Coverage on Envoy Medical (COCH) with Buy Rating and $2.04 Target

On October 6, 2026, Lake Street began coverage of Envoy Medical (NASDAQCM:COCH) with a Buy recommendation.

Prior to the rating, Envoy Medical closed at $0.65 on October 5, 2026. Over the preceding week, the stock fell 5.94% from a close of $0.69 on September 28, 2026, and declined 8.31% from a close of $0.71 on September 4, 2026.

The consensus target price remains $2.04, representing a 213.36% implied upside from the recent $0.65 price. The target has not changed since September 15, 2026.

Analyst sentiment for the period ending September 1, 2026, reflects eight total ratings: two Strong Buy, five Buy, one Hold, and no Sell or Strong Sell. Positive recommendation percentage stands at 87.5%, while the hold rate is 12.5%.

Recent analyst actions

Date Analyst Prior Latest recommendation Action
October 6, 2026 Lake Street Buy initiated coverage

Source link